You will be redirected to:
Paris, Levallois-Perret, June 23, 2022 - Keyrus Life Science announces the launch of its new visual identity strengthening its synergies with the Keyrus Group to address the most pressing challenges of its clients in the life science industry and to drive clinical research forward.
"The development of Keyrus Life Science is based on the premise that it is only by giving meaning to data as quickly as possible that mankind can successfully tackle the major existing and emerging health issues", declares Michael Attlan, VP, Head of Life Science Innovation & Strategic Engagements. "Keyrus Life Science is a unique Connected-CRO that enhances the performance, the speed and the agility of clinical trials by making data matter."
Relying on a strong scientific background built from the combined international expertise of 300 consultants and 25 years of experience, Keyrus Life Science connects in-depth industry know-how, life data sciences and digital enablement. It fully leverages both clinical research ecosystems and Real-World Evidence (RWE), thus enhancing the reliability, innovative capacity, agility, and, above all, speed of execution of clinical research activities.
Keyrus Life Science unlocks for its clients the means to achieve digitalization across all life science industry segments and throughout all phases of the R&D cycle, from the earliest clinical stages, through to real world evidence and insights in a post-marketing setting.
By capitalizing on digital technologies, data sciences and honed industry expertise, Keyrus Life Science creates a unique value proposition, driven by innovation, passion and scientific rigor. Keyrus Life Science accompanies its clients in:
Framing their clinical development strategies
Operationalizing their clinical development
Implementing RWE and late phase projects
Enabling life data science boosters
Reaching the next level in digital innovation
"Keyrus Life Science fits into the Keyrus Group’s vision and shares both its values, and its keen innovative spirit", declares Eric Cohen, CEO of Keyrus. "Drawing upon highly original ways of using and valorizing health data, Keyrus Life Science’s proposition is unique in the market today. Combined with the Keyrus Group’s longstanding data-digital expertise, Keyrus Life Science’s offerings thus bring innovative and concrete solutions to companies in this sector and support them in reinventing their clinical research strategy."
Stay updated on the latest articles, events, and more
Blog post
Nowadays, all companies active in the life science ecosystem consider data as a crucial asset to their success. Pharma companies are collecting more and more information during their clinical trials or commercial and medical activities. Clinical laboratories have to deploy complex data infrastructures to better serve their patients and clients, and Biotech and MedTech companies need to gather and analyze a lot of scientific and technical data.
Press release
Paris 9th January, 2023 (France) - Today, EvidentIQ, a leading clinical data science group and Keyrus Life Science, the international Connected Contract Research Organization (C²RO), announced the signing of a strategic partnership. The synergy between both companies will improve automation, efficiency and agility in clinical research by leveraging new eClinical capabilities.
Press release
Paris, Levallois-Perret, November 7th, 2022 - Keyrus Life Science and Parean Biotechnologies will join their expertise in data science and technologies to meet the most critical challenges for clients in the fields of biometry, biostatistics and bioinformatics.
Event
This summer was very busy and interesting for the Keyrus Life Science North America Team. We attended three pivotal life science conferences: Decentralized Clinical Trials Conference, BIO International Convention, and DIA Conference.
Expert's opinion
Digitalization, data and connectivity has become part of our daily lives in all its dimensions.
Expert's opinion
Clinical trials produce a massive amount of data. In most cases, the challenge lies less in the volume of data to process, but more in its diversity. The sources of data are indeed numerous and do not stop increasing.
Blog post
The World Heart Day, an occasion to remind us all, that cardiovascular diseases (CVD) causes more than 18 million of deaths per year.
Event
Today, September 21st, is the World Alzheimer’s Day, so let’s do a quick review of the investigated therapeutic targets to find a cure to this pathology
Event
Keyrus Life Science joined the Keyrus Foundation in the team sports challenge 'Connected against hunger'
Blog post
We are happy to have partnered with European Centre for Clinical Research Training (ECCRT) in training our experts at Keyrus Life Science.